BSAM
Blue Square Asset Management’s Novartis NVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.94M | Buy |
24,283
+3,089
| +15% | +$374K | 1.38% | 29 |
|
|
2025
Q1 | $2.36M | Sell |
21,194
-343
| -2% | -$38.2K | 1.27% | 28 |
|
|
2024
Q4 | $2.1M | Buy |
21,537
+427
| +2% | +$41.6K | 1.04% | 33 |
|
|
2024
Q3 | $2.43M | Buy |
21,110
+426
| +2% | +$49K | 1.3% | 25 |
|
|
2024
Q2 | $2.2M | Buy |
20,684
+1,744
| +9% | +$186K | 1.28% | 27 |
|
|
2024
Q1 | $1.83M | Buy |
18,940
+8,285
| +78% | +$801K | 1.22% | 28 |
|
|
2023
Q4 | $1.08M | Buy |
10,655
+2,226
| +26% | +$225K | 0.72% | 44 |
|
|
2023
Q3 | $859K | Sell |
8,429
-1,262
| -13% | -$129K | 0.63% | 45 |
|
|
2023
Q2 | $978K | Buy |
9,691
+1,878
| +24% | +$190K | 0.7% | 48 |
|
|
2023
Q1 | $719K | Buy |
+7,813
| New | +$719K | 0.47% | 31 |
|
|
2020
Q3 | – | Sell |
-705
| Closed | -$62K | – | 150 |
|
|
2020
Q2 | $62K | Buy |
+705
| New | +$62K | 0.04% | 117 |
|